Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Report on the management of staghorn calculi.

BIBLIOGRAPHIC SOURCE(S)

  • American Urological Association Education and Research, Inc.. Report on the management of staghorn calculi. Linthicum (MD): American Urological Association Education and Research, Inc.; 2005. Various p. [81 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Note from the National Guideline Clearinghouse: The recommendations without the associated supporting text have been excerpted from the guideline. For full context, please refer to the original guideline document.

Definitions for the treatment guideline statements (standard, recommendation, and option) and "index patient" are given at the end of the "Major Recommendations" field.

Treatment Guidelines for the Index Patient

Standards

  1. A newly diagnosed patient should be actively treated.
  2. The patient must be informed about the relative benefits and risks associated with the active treatment modalities.

Recommendations

  1. Percutaneous nephrolithotomy should be the first treatment utilized for most patients.
  2. If combination therapy is undertaken, percutaneous nephroscopy should be the last procedure for most patients.
  3. Shock-wave lithotripsy monotherapy should not be used for most patients; however, if it is undertaken adequate drainage of the treated renal unit should be established before treatment.
  4. Open surgery (nephrolithotomy by any method) should not be used for most patients.

Options

  1. Shock-wave lithotripsy monotherapy may be considered in patients with small-volume staghorn calculi with normal collecting-system anatomy.
  2. Open surgery can be considered for patients in whom the stone is not expected to be removed by a reasonable number of less invasive procedures.

Recommendations for Non-index Patients

  1. Nephrectomy should be considered when the involved kidney has negligible function.
  2. Shock-wave lithotripsy monotherapy should not be used for patients with staghorn or partial staghorn cystine stones.

Option for Non-index Patients

  1. Shock-wave lithotripsy monotherapy or percutaneous-based therapy may be considered for children.

Definitions:

Treatment Guideline Statements

The present treatment guideline statements are graded with respect to three levels of flexibility: A "standard" has the least flexibility as a treatment policy; a "recommendation" has significantly more flexibility; and an "option" is even more flexible. These three levels of flexibility are defined as follows:

  1. Standard: A guideline is a standard if (1) the health outcomes of the alternative interventions are sufficiently well known to permit meaningful decisions, and (2) there is virtual unanimity about which intervention is preferred;
  2. Recommendation: A guideline is a recommendation if (1) the health outcomes of the alternative interventions are sufficiently well known to permit meaningful decisions, and (2) an appreciable but not unanimous majority agrees on which intervention is preferred; and
  3. Option: A guideline is an option if (1) the health outcomes of the alternative interventions are not sufficiently well known to permit meaningful decision, or (2) preferences are unknown or equivocal.

Index Patient

Standards, recommendations, and options for the treatment of patients with staghorn calculi apply to an "index patient." In this guideline, the index patient is defined as an adult with a staghorn stone (non-cystine, non-uric acid) who has two functioning kidneys (function of both kidneys is relatively equal) or a solitary kidney with normal function, and whose overall medical condition, body habitus, and anatomy permit performance of any of the four accepted active treatment modalities, including the use of anesthesia.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The guidelines are generally based on current professional literature, clinical experience and expert opinion. The type of supporting evidence is not specifically stated for each recommendation.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American Urological Association Education and Research, Inc.. Report on the management of staghorn calculi. Linthicum (MD): American Urological Association Education and Research, Inc.; 2005. Various p. [81 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2005

GUIDELINE DEVELOPER(S)

American Urological Association Education and Research, Inc. - Medical Specialty Society

SOURCE(S) OF FUNDING

American Urological Association Education and Research, Inc. (AUA)

GUIDELINE COMMITTEE

Nephrolithiasis Guideline Panel

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: Glenn M. Preminger, M.D., Chairman; Dean G. Assimos, M.D., Vice-chairman; James E. Lingeman, M.D.; Stephen Y. Nakada, M.D.; Margaret S. Pearle, M.D., Ph.D.; J. Stuart Wolf, Jr., M.D.

Consultants and Staff: Hanan S. Bell, Ph.D.; Patrick M. Florer; Jane Murphy, Ph.D.; Carol Schwartz, M.P.H.; Edith Budd; Michael Folmer

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Funding of the committee was provided by the American Urological Association (AUA). Committee members received no remuneration for their work. Each member of the committee provided a conflict of interest disclosure to the American Urological Association.

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on April 21, 2005. The information was verified by the guideline developer on May 13, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is copyrighted by the American Urological Association Education and Research, Inc. (AUA).

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo